LONDON, Nov. 16, 2017 /PRNewswire/ -- Fore Pharma announced the results of its Psoriasis patients study in a new report 'Global Psoriasis Epidemiology and Patient Flow Analysis - 2017'.
Download the full report: https://www.reportbuyer.com/product/3895271The report provides insights into Psoriasis epidemiology, Psoriasis diagnosed patients, and Psoriasis treatment rate for top seven pharmaceutical markets. The study measures
key indicators such as prevalence of Psoriasis derived from epidemiological analysis, percentage of patients diagnosed with Psoriasis, and percentage of patients treated with a therapy. The study helps executives estimate Psoriasis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions. The report provides estimates and forecasts of Psoriasis prevalence, Psoriasis diagnosis rate, and Psoriasis treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources. Key Features of the Report:
- Psoriasis Patient Flow - Psoriasis Prevalence - Psoriasis Diagnosed Patients - Psoriasis Treated PatientsDownload the full report: https://www.reportbuyer.com/product/3895271
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: email@example.com
Tel: +44 208 816 85 48 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/global-psoriasis-epidemiology-and-patient-flow-analysis---2017-300558267.html